Rinvoq 30 mg/1

Rinvoq 30 mg is an extended-release tablet used to manage inflammatory conditions. This medication, containing upadacitinib, is designed for oral administration and is manufactured by AbbVie Inc. in the USA.

Rinvoq 30 mg is primarily used to help manage symptoms of inflammatory conditions. It is often prescribed for conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Patients may wonder, 'What is Rinvoq used for?' This medication is designed to reduce inflammation and improve mobility in affected joints.

Common effects of Rinvoq 30 mg may include nausea, dizziness, and upper respiratory infections. Some users might experience fatigue or headaches. It's important to note that individual responses can vary, and not everyone will experience these effects.

Rinvoq 30 mg should be handled with care, especially for those with a history of infections or liver problems. It is essential to follow the advice of a healthcare provider regarding its use. Always store the medication as directed to maintain its effectiveness.

Rinvoq 30 mg may interact with certain medications, including those that affect the immune system or liver enzymes. It's crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect how this medication works.